We will advance contract manufacturing operations from the customer's perspective!
Our company conducts contract manufacturing of pharmaceuticals from the customer's perspective, based on our extensive experience in domestic and international contract manufacturing. We have a robust support system for contract manufacturing from our research and production technology departments, characterized by continuous improvement in manufacturing technology and stable quality control capabilities. We offer competitive contract prices, so please feel free to contact us. 【Contract Manufacturing Scope】 ■ Injectable liposome formulations (scheduled to start in January 2020) ■ Penicillin-based injectable drugs (vial formulations, bag formulations, freeze-dried powders) ■ Solid cephalosporin oral medications ■ Bulk active pharmaceutical ingredients (penicillin API) *For more details, please feel free to contact us.
Inquire About This Product
basic information
【Production Capacity】 ■ Injectable Liposome Formulation Plant (Scheduled to start operations in January 2020) - 35L and 350L preparation tanks - High pharmacological activity compatibility ■ Penicillin-based Injectable Drug Plant - Annual production capacity of vials (8 million units) - Annual production capacity of double bags (4 million bags) ■ Solid Cephalosporin Oral Medication Plant - Annual production capacity of tablets: 400 million tablets - Monthly production capacity of a single item: 20 million tablets - Capable of producing tablets, hard capsules, powders, and granules *For more details, please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company was established through the merger of Fujifilm RI Pharma and Toyama Chemical to strengthen the collaboration between "diagnosis" and "treatment" and accelerate new drug development. While closely collaborating with Fujifilm, which conducts research on new drugs and medical system businesses, we aim to provide "appropriate medications and treatment methods based on more accurate diagnoses for each diverse patient," addressing unmet medical needs.